Breakthrough: China’s First Approved Solid Tumor CAR-T Therapy Paves the Way for Industry Transformation
June 22, 2026 — 22:06 CST
This Data Is Locked!
This area is available only to Subscribers.
The National Medical Products Administration has approved the listing of KaiXing Life Technology (Shanghai) Co., Ltd.'s CAR-T therapy, named Kailimei, for the treatment of advanced... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
